Tag: Arthritis: Rheumatoid
Cancer Risks Examined in Rheumatoid Arthritis Patients
Increased incidences found for lymphoma, lung cancer (in male patients), and cervical cancer
Filgotinib Bests Placebo in Tx of Refractory Rheumatoid Arthritis
Clinical response rate higher among patients with active RA resistant to treatment with biologic agents
Initial Sustained Remission Common in Rheumatoid Arthritis
Male sex, early RA, treatment-naive, shorter time to remission tied to greater likelihood of remission
Elderly-Onset Rheumatoid Arthritis Ups Bone Erosion Risk
Even two years of clinical remission does not protect against bone erosions
Rheumatoid Arthritis Remission Cuts Risk for CV Complications
Maintenance of remission in rheumatoid arthritis lowers risk for subclinical, clinical atherosclerosis
Glucocorticoid Tapering Feasible for Rheumatoid Arthritis Patients
Findings observed in patients achieving low disease activity, remission while receiving tocilizumab
Postoperative Infection Rate Similar Across Biologics in RA
Glucocorticoid use ups risk for hospitalized infection, prosthetic joint infection after arthroplasty
Disability Often Precedes Rheumatoid Arthritis Diagnosis
Functional disability continues even after diagnosis and treatment
Risk Factors ID’d for Rheumatoid Arthritis Complications
Disease duration and socioeconomic factors tied to likelihood of hospitalizations and infections
Statins Safe, Effective in Rheumatoid Arthritis Patients
However, cardiovascular event rates are low, do not require a primary prevention strategy for all patients
